The histone deacetylase inhibitor ITF2357 has anti-leukemic activity in vitro and in vivo and inhibits IL-6 and VEGF production by stromal cells
2007
The histone deacetylase inhibitor ITF2357 has anti-leukemic activity in vitro and in vivo and inhibits IL-6 and VEGF production by stromal cells
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
52
References
96
Citations
NaN
KQI